Bayer CropScience Ltd logo

Bayer CropScience Ltd

BAYERCROP NSE

Key Fundamentals

SmallcapPesticides & AgrochemicalsChemicals
Market Cap
₹18,282 Cr
Volatility
Moderate
P/E Ratio
25.2
EBITDA
₹969 Cr
Return on Equity
23.24%
Debt to Equity
0.03
Book Value
₹659.9
EPS
₹148.24
52W High
₹5,706
52W Low
₹4,030

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bayer CropScience Ltd insights

46 extracted metrics + investor summaries across FY14–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

5
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 3.66%.
  • Company has been maintaining a healthy dividend payout of 93.8%
  • Company's working capital requirements have reduced from 74.0 days to 56.1 days

Weaknesses

1
  • The company has delivered a poor sales growth of 5.90% over past five years.

Growth Rate

Revenue Growth
3.16% ↘
Net Income Growth
21.34% ↘
Cash Flow Change
311.64% ↗
ROE
16.61% ↗
ROCE
16.52% ↗
EBITDA Margin (Avg.)
16.03% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk medium

Bayer CropScience Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹18,390 Cr, trading at a PE of 25.2x with a consistent ROE averaging 23-24% over the last 3-5 years. The stock has declined 27% over the past year despite a 24% TTM profit growth, while revenue has contracted 3% on a trailing twelve-month basis.

Bull Case 7
  • Company is virtually debt-free, providing significant financial flexibility and balance sheet resilience in a capital-intensive sector
  • Healthy ROE of 24% in the last year and 23-24% averaged over 3-5 years indicates efficient capital allocation and strong profitability
  • Dividend yield of 3.65% is attractive relative to sector peers, supported by a high payout ratio of 93.8%
  • TTM profit growth of 24% demonstrates margin expansion capability even in a period of revenue contraction
  • Working capital cycle has improved from 74.0 days to 56.1 days, reflecting better operational efficiency and cash conversion
  • 10-year compounded profit growth of 8% and sales growth of 7% show a track record of steady long-term earnings expansion
  • Price-to-book ratio of 6.23x, while optically high, is supported by the company's consistently high return on equity profile above 21% over a decade
Bear Case 8
  • Stock price has declined 27% over the past year, significantly underperforming the broader market and indicating weak investor sentiment
  • TTM revenue has contracted by 3%, signaling demand headwinds or pricing pressure in the agrochemicals segment
  • 5-year compounded sales growth of only 5.9% is notably weak for the Indian chemicals sector which has seen higher growth rates
  • Stock CAGR of -8% over 5 years and 0% over 10 years shows persistent long-term price underperformance despite decent earnings growth
  • 3-year compounded profit growth of just 1% suggests earnings stagnation in the medium term before the recent TTM uptick
  • Payout ratio of 93.8% leaves very little room for reinvestment into growth initiatives, R&D, or capacity expansion
  • 3-year stock CAGR of -4% indicates the market has been de-rating the company over the medium term despite stable fundamentals
  • PE of 25.2x combined with low single-digit sales growth implies limited earnings growth runway unless margin expansion continues sustainably

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 17h ago
Positives 2
  • Q1FY27 profit jumps 15% YoY Aug 5

    Net profit rose 15% YoY to ₹3,216 million in Q1FY27, driven by strong Agri Care sales and gains from divestment of marketing rights.

  • Strong FY26 revenue and dividend Jul 21

    68th Annual Report shows ₹56,750 million revenue, ₹6,892 million net profit, and total dividend of ₹150 per share for FY2025-26.

Neutral 2
  • New Chairman appointed from Sep Aug 5

    Ravi Kirpalani appointed as Additional Independent Director and Chairman effective Sep 12, 2026, succeeding Pankaj Patel.

  • Bayer AG raises stake to 20.34% Jul 24

    Bayer AG acquired 53,54,030 shares from Bayer CropScience AG via block deal on Jul 8, 2026 at ₹4,122.30 per share, raising its stake to 20.34%.

TL;DR: Bayer CropScience is delivering solid earnings growth with a 15% profit jump in Q1FY27 and healthy FY26 financials including a generous ₹150/share dividend. There are no visible headwinds in recent news flow. Parent Bayer AG increasing its stake signals confidence in the Indian subsidiary. The trend is positive with earnings momentum intact heading into FY27.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1,740
1,617
955
792
1,631
1,738
1,057
1,046
1,915
1,553
1,106
1,101
1,835
Expenses
1,315
1,312
827
695
1,317
1,554
1,037
876
1,566
1,348
989
898
1,467
Operating Profit
425
305
128
97
314
184
20
171
348
205
117
203
368
OPM %
24%
19%
13%
12%
19%
11%
1.9%
16%
18%
13%
11%
18%
20%
Other Income
21
16
15
29
27
24
32
37
19
14
16
47
89
Interest
8
4
3
5
4
3
4
6
5
4
5
6
4
Depreciation
31
12
15
16
22
14
15
34
27
14
15
38
50
PBT
406
306
124
105
316
190
34
168
335
200
113
206
402
Tax %
19%
27%
25%
9%
20%
28%
-2%
15%
17%
24%
15%
21%
20%
Net Profit
328
223
93
96
254
136
34
143
279
153
96
162
322
EPS in Rs
73.09
49.6
20.72
21.36
56.56
30.33
7.61
31.89
62.01
33.98
21.29
36.07
71.56
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
3,660
2,769
2,803
2,710
3,167
3,609
4,261
4,734
5,140
5,106
5,473
5,675
5,595
Expenses
3,144
2,334
2,389
2,300
2,684
2,883
3,450
3,923
4,216
4,147
4,783
4,801
4,702
Operating Profit
516
435
414
410
483
726
812
812
924
959
691
874
893
OPM %
14%
16%
15%
15%
15%
20%
19%
17%
18%
19%
13%
15%
16%
Other Income
88
82
70
39
51
-64
69
112
168
76
118
95
165
Interest
5
10
7
11
10
14
13
13
22
20
17
20
19
Depreciation
25
25
29
33
44
65
74
64
80
74
85
94
117
PBT
574
482
448
404
480
583
794
847
990
941
707
855
922
Tax %
33%
35%
35%
26%
30%
19%
38%
24%
23%
21%
20%
19%
—
Net Profit
383
315
291
300
337
474
493
645
758
740
568
689
732
EPS in Rs
105
89.13
82.31
87.41
98.18
106
110
144
169
165
126
153
163
Div. Payout %
20%
19%
21%
21%
18%
24%
105%
104%
77%
85%
99%
98%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
37
35
35
34
34
45
45
45
45
45
45
45
Reserves
1,996
1,804
2,021
1,744
2,205
2,528
2,505
2,479
2,667
2,804
2,806
2,921
Borrowings
0
0
0
0
0
2
26
86
74
47
105
82
Other Liabilities
740
597
769
756
1,310
1,262
1,663
1,742
1,893
1,701
2,290
2,652
Total Liabilities
2,773
2,437
2,825
2,535
3,549
3,836
4,239
4,353
4,679
4,597
5,246
5,699
Fixed Assets
322
290
342
334
440
468
425
468
462
414
470
458
CWIP
1
17
24
36
47
56
76
98
109
119
119
127
Investments
29
68
50
0
0
41
52
38
41
54
35
57
Other Assets
2,422
2,062
2,410
2,164
3,062
3,270
3,686
3,749
4,066
4,010
4,622
5,056
Total Assets
2,773
2,437
2,825
2,535
3,549
3,836
4,239
4,353
4,679
4,597
5,246
5,699
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
200
206
157
121
433
666
687
216
609
952
262
1,078
Investing
485
16
-8
38
-113
-29
7
64
83
0
86
72
Financing
-42
-590
-73
-581
-158
-148
-556
-703
-613
-656
-619
-624
Net Cash Flow
644
-367
76
-421
162
489
138
-424
79
296
-272
527
Free Cash Flow
297
170
108
80
378
638
656
168
537
912
222
1,014
CFO/OP
76
86
74
53
132
110
105
59
92
113
61
142
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
57
53
72
89
81
73
65
77
69
69
63
72
Inventory Days
85
169
178
175
294
206
226
235
268
222
319
289
Days Payable
40
52
67
67
164
101
142
127
129
87
148
167
Cash Conversion Cycle
102
171
184
197
211
177
149
185
208
204
234
193
Working Capital Days
53
92
104
134
116
77
61
84
86
78
88
56
ROCE %
31%
25%
23%
22%
25%
30%
31%
31%
34%
34%
25%
29%

Shareholding Pattern

As of Jun 2026
Promoters 71.43%
DIIs 11.64%
Public 8.63%
Others 4.33%
FIIs 3.97%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
71.43%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
3.62%
3.63%
3.30%
3.42%
3.49%
3.64%
3.79%
3.84%
3.89%
3.97%
DIIs
12.44%
11.30%
12.19%
12.49%
12.85%
13.01%
12.66%
12.79%
12.64%
13.01%
13.21%
12.68%
12.80%
12.47%
12.08%
11.70%
11.55%
11.38%
11.21%
11.46%
11.89%
11.64%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
8.48%
8.43%
8.70%
8.48%
8.22%
8.01%
8.19%
8.05%
8.23%
8.00%
7.59%
7.84%
7.74%
7.96%
8.58%
8.76%
8.88%
8.93%
9.08%
8.78%
8.41%
8.63%
Others
7.64%
8.83%
7.68%
7.60%
7.50%
7.55%
7.72%
7.72%
7.69%
7.56%
7.77%
8.05%
4.41%
4.51%
4.61%
4.68%
4.65%
4.62%
4.49%
4.50%
4.39%
4.33%
No. of Shareholders
65,285
65,088
62,321
62,178
60,230
57,760
57,896
57,048
57,253
48,404
45,329
46,907
45,852
46,201
51,289
54,289
54,216
55,753
58,109
58,571
55,795
58,884

Documents

1
Concall - Aug 2017 Aug 2017
2
Concall - Jun 2018 Jun 2018
3
Concall - Nov 2018 Nov 2018
4
Concall - May 2019 May 2019
5
Concall - Nov 2019 Nov 2019

Frequently Asked Questions about Bayer CropScience Ltd

What does Bayer CropScience Ltd do?
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
Where is Bayer CropScience Ltd (BAYERCROP) listed?
Bayer CropScience Ltd is listed on the Indian stock exchanges. It is listed on NSE: BAYERCROP and BSE: 506285. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Bayer CropScience Ltd belong to?
Bayer CropScience Ltd operates in the Chemicals sector within the Pesticides & Agrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Bayer CropScience Ltd?
Bayer CropScience Ltd has a market capitalisation of approximately ₹18282.44 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Bayer CropScience Ltd?
The Price-to-Earnings (PE) ratio of Bayer CropScience Ltd is 25.20. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Bayer CropScience Ltd?
Over the past 52 weeks, Bayer CropScience Ltd has traded between a low of ₹4,030 and a high of ₹5,706. This range helps investors understand the stock's price volatility and recent trading levels.
Does Bayer CropScience Ltd pay dividends?
Yes, Bayer CropScience Ltd has a dividend yield of 3.66%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Bayer CropScience Ltd?
Bayer CropScience Ltd has a Return on Equity (ROE) of 23.24%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Bayer CropScience Ltd on Tapetide?
On Tapetide, you can view Bayer CropScience Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Website bayer.in
CEO Mr. Simon-Thorsten Wiebusch
Employees 1,169
Listed 2010-01-08
Face Value ₹ 10
Issued Size 5,01,07,246

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List